The China spinal fusion market is expected to register double digit growth over the next decade, according to Future Market Insights analysis.
Here are five key trends:
1. Some major factors supporting the spinal fusion market growth in China are the increasing rate of aging population with spine-related diseases and injuries as well as Chinese residents' rising incomes.
2. The emergence of advanced technologies, such as minimal invasive surgery and enhanced implant materials, are allowing people of all age groups to receive fusion procedures, leading to further market growth.
3. Additionally, the price sensitive Chinese population is responsive to the treatment price that is anticipated to drop considerably due to the increasing market competition.
4. Factors restraining the China spinal fusion market include reimbursement cuts, heavy government regulations and surgical risk factors.
5. Some key players in the China spinal fusion market are Depuy Synthes, Zimmer Biomet, Medtronic, NuVasive, Stryker, Orthofix, B. Braun Aesculap, Trauson and Weigao Orthopaedic Device Company, which signed an exclusive distribution agreement with Amedica in April.